|
EBS
|
Emergent Biosolutions, Inc.
|
US
|
NYSE
|
|
HGEN
|
Humanigen, Inc.
|
US
|
NASDAQ
|
|
JAZZ
|
Jazz Pharmaceuticals plc
|
US
|
NASDAQ
|
|
MESO
|
Mesoblast Limited
|
US
|
NASDAQ
|
|
OCGN
|
Ocugen, Inc.
|
US
|
NASDAQ
|
|
PLUR
|
Pluri Inc.
|
US
|
NASDAQ
|
|
CYYNF
|
Cynata Therapeutics Ltd Ordinar
|
US
|
OTC
|
|
ENDV
|
Endonovo Therapeutics Inc
|
US
|
OTC
|
|
1T3
|
Syndax Pharmaceuticals Inc
|
DE
|
F
|
|
MAAT
|
Maat Pharma SA
|
FR
|
PA
|
|
PSTI
|
Pluristem
|
IL
|
TA
|
|
MDNAF
|
Medicenna Therapeutics Corp
|
US
|
US
|
|
1S9
|
Seres Therapeutics Inc
|
DE
|
F
|
|
4RD
|
MAAT PHARMA S.A. EO-1
|
DE
|
F
|
|
51S
|
CYNATA THERAPEUTICS
|
DE
|
F
|
|
LWB
|
Mesoblast Limited
|
DE
|
F
|
|
MDNA
|
Medicenna Therapeutics Corp
|
CA
|
TO
|
|
CYP
|
Cynata Therapeutics Ltd
|
AU
|
AU
|